Literature DB >> 14550953

Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors.

Luping Wang1, Jiyao Yu, Jian Ni, Xue-Ming Xu, Jianjin Wang, Haoyong Ning, Xu-Fang Pei, Jinguo Chen, Shanmin Yang, Charles B Underhill, Lei Liu, Joeri Liekens, Joseph Merregaert, Lurong Zhang.   

Abstract

The extracellular matrix protein 1 (ECM1) is a secreted protein that has been implicated with cell proliferation, angiogenesis and differentiation. In the present study, we used immunohistochemical staining to examine the expression of ECM1 in a panel of human tumors and found that it was closely correlated with some types of tumors including: invasive breast ductal carcinoma (83%), esophageal squamous carcinoma (73%), gastric cancer (88%) and colorectal cancer (78%). Significantly, ECM1expression was correlated with the metastatic properties of the tumors. Primary breast cancers that had formed metastases were 76% positive while those that had not metastasized were only 33% positive. ECM1 expression was also correlated with PCNA a marker for proliferation, but not with CD34, a marker for endothelial cells. These results indicate that ECM1 tends to be preferentially expressed by metastatic epithelial tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550953     DOI: 10.1016/s0304-3835(03)00350-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  46 in total

1.  HER2 Signaling in Breast Cancer.

Authors:  Incheol Shin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  ECM1 regulates tumor metastasis and CSC-like property through stabilization of β-catenin.

Authors:  K-m Lee; K Nam; S Oh; J Lim; R K Kim; D Shim; J-h Choi; S-J Lee; J-H Yu; J W Lee; S H Ahn; I Shin
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

3.  Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma.

Authors:  Hao Chen; Wei-Dong Jia; Jian-Sheng Li; Wei Wang; Ge-Liang Xu; Jin-Liang Ma; Wei-Hua Ren; Yong-Sheng Ge; Ji-Hai Yu; Wen-Bin Liu; Chuan-Hai Zhang; Yong-Cang Wang
Journal:  Med Oncol       Date:  2010-12-03       Impact factor: 3.064

4.  ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.

Authors:  Electron Kebebew; Miao Peng; Emily Reiff; Quan-Yang Duh; Orlo H Clark; Alex McMillan
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

5.  Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.

Authors:  P Gómez-Contreras; J M Ramiro-Díaz; A Sierra; C Stipp; F E Domann; R J Weigel; G Lal
Journal:  Clin Exp Metastasis       Date:  2016-10-21       Impact factor: 5.150

6.  ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1).

Authors:  Zhenhu Li; Yuan Zhang; Zhiduo Liu; Xiaodong Wu; Yuhan Zheng; Zhiyun Tao; Kairui Mao; Jie Wang; Guomei Lin; Lin Tian; Yongyong Ji; Meiling Qin; Shuhui Sun; Xueliang Zhu; Bing Sun
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

7.  A Novel ECM1 Splice Site Mutation in Lipoid Proteinosis: Case Report plus Review of the Literature.

Authors:  Linda K Rey; Jürgen Kohlhase; Katrin Möllenhoff; Gabriele Dekomien; Jörg T Epplen; Sabine Hoffjan
Journal:  Mol Syndromol       Date:  2016-03-15

8.  Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.

Authors:  Kristin Lm Boylan; John D Andersen; Lorraine B Anderson; LeeAnn Higgins; Amy Pn Skubitz
Journal:  Proteome Sci       Date:  2010-06-14       Impact factor: 2.480

9.  Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique.

Authors:  Paweena Kreunin; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  Proteomics       Date:  2004-09       Impact factor: 3.984

10.  IBD candidate genes and intestinal barrier regulation.

Authors:  Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.